Top Section/Ad
Top Section/Ad
Most recent
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
Pair enjoyed strong execution and tight pricing as US high grade credit remained resilient in the face of a sell-off in equity markets
More articles/Ad
More articles/Ad
More articles
-
'Aggressive' pricing fails to attract investors -
US firm ramps up in industry it has picked out as a 'megatrend'
-
More corporates waiting to pounce, but blackouts and Easter set to hamper supply
-
Saudi pharmacy chain Nahdi has started trading on the Tadawul following the largest IPO in the Kingdom since December 2019
-
GSK’s consumer spin-off roadshows amid calm after Fed and BofE meetings
-
Major shareholder reduces stake in Spanish pharmaceuticals company
